Lundbeck Research USA, Inc. and BioFocus Sign Compound Management Agreement
News Jan 26, 2011
Under the terms of this agreement, Compound Focus will manage Lundbeck’s liquid chemical library collection, distributing screening sets to high throughput screening centers in both the USA and Europe. These services will be provided by Compound Focus’ compound management facility in South San Francisco, USA.
“We are pleased to welcome Lundbeck Research USA, Inc. as a new client,” said Scott Snyder, Compound Focus’ General Manager. “Compound Focus continues to attract commercial, government and charitable organizations that see our state of the art automation and compound management experience as a complement to their discovery operations.”
About Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. is engaged in drug discovery aimed at treating CNS diseases by designing small molecule therapeutics. Lundbeck Research USA, Inc. mission is to improve the quality of life for those suffering from psychiatric and neurological disorders.
About Compound Focus
Compound Focus, Inc. is a service division of BioFocus and provides a range of compound management services. It is home to sample collections owned by government, academic and commercial organizations and to the National Institutes of Health Molecular Libraries Small Molecule Repository.
Researchers have successfully optimized a hit from a whole cell screening of a 10000-compound library to deliver the first novel fully synthetic and rationally designed anti-Wolbachia drug, AWZ1066S, which could potentially be used to treat onchocerciasis and lymphatic filariasis (LF).READ MORE
3rd International Conference and Exhibition on Nanomedicine and Drug Delivery
Mar 13 - Mar 14, 2019